OXYGEN TO OXYGEN

ACTIVATES BODY'S
OXYGEN NUCLEUS
BY PAPIMI'S
OXYGEN DISCHARGES

THE ORIGINAL AND ONLY DEVICE
USING WORLD PATENTED APPROPRIATE
OXYGEN PLASMA DISCHARGES
TO ACTIVATE BODY'S OXYGEN
A RESULT OF OVER 20 YEARS
LIFE'S DEDICATED RESEARCH

BY PROFESSOR PAPPAS

FAST INTRODUCTION

what is papimi for beginners click here

 

 

 

Interesting Links:

 

www.papimi.tv

 www.painangels.com 

 www.drwellness.net

 www.papimi.de

 www.papimi.hu 

 www.papimi.biz

 www.papimi.pl

 www.papimi.com.au  

 

Professor Pappas's site: www.papimi.gr       

 

 

 

Papimi will be in the EXPOVITAL Health Fair : Madrid, SPAIN  7 - 9 March 2008 

 

Papimi will be in the FISALUD      Health Fair : Madrid SPAIN, 27 - 30 November 2008  

 

PAPIMI Conferences

 

PAPIMI device saved a Ski World Champion's leg and gave him the opportunity to claim a brand-new medal

 

115 Reports  On Over One Thousand  Multiple CASES 

 

MIRACLE HORSE RECOVERY BECOMING CHAMPION click here for NBC TV VIDEO few minutes required to download

 

APPROVALS AND RELATED MATTERS

 

APPLICATION CENTERS / SERVICES 

 

Welcome to the PAP Ion Magnetic Inductor site for the US  and Canada.

This device has been developed more than two decades ago by Prof. Dr. Panos Pappas, inventor, designer and patent owner of the PAP IMI type device.      

The PAPIMI device has been in the market for agricultural and veterinary use since the early ‘90, and clinical data is being gathered for further approval in the US and Canada for human use.

The PAPIMI device was approved in the European Union in 2004 and in Canada in 1993.

The Canadian approval expired and a re-application is in process to comply with new requirements for electromagnetic devices in medicine.

We are also in the process to comply with all FDA requirements to have the PAPIMI device cleared in the US.

The professionals who use the device in Europe are very satisfied with the results; however all medical claims have to be demonstrated with further clinical studies.

               New exchangeable probe, click to enlarge

 This site is under construction

 

About Us

 

Scientific Information 

 

News and future development in the United States and Canada 

 

Clinical Trials with the PAP DEVICE Asklipios Model for Human Use 

 

HUD – PAP DEVICE Asklipios Model for the therapy of patients affected with Friedreich Ataxia 

 

HUD – PAP DEVICE Asklipios Model for the concomitant therapy for unsatisfactory controlled seizures refractory to all antiepileptic drugs and surgery 

 

PAP Device Heraklitos model for veterinary use only

 

 

Counter
Automatic Banner Code Placement-                   Provided by RightStats.Com